Scientists have identified an initiating molecular mechanism in sporadic Alzheimer’s disease (AD). The study provides new information about generation of damaging amyloid beta (A-beta) plaques within the AD brain and underscores the importance of developing new preventative and disease-modifying therapies for AD, especially those aimed at interrupting pathological A-beta-production.